发明名称 |
NK CELL RECEPTOR CONJUGATES FOR TREATING MALIGNANCIES |
摘要 |
The present invention relates generally to compositions useful in therapies involving the selective destruction of tumor cells in vivo. In particular, this invention relates to a conjugate which comprises a target recognition segment and an active cytotoxic segment. The target recognition segment comprises a receptor specific to NK cells, wherein the receptor binds to a cellular ligand expressed on the surface of a tumor cell, and the active segment comprises an agent capable of exerting a cytotoxic effect on the tum or cell. The target recognition segment derived form the natural killer recepto r NKp30 has been found to be particularly effective in vivo.
|
申请公布号 |
CA2509400(A1) |
申请公布日期 |
2004.06.24 |
申请号 |
CA20032509400 |
申请日期 |
2003.12.09 |
申请人 |
NATSPEARS LTD. |
发明人 |
PORGADOR, ANGEL;MANDELBOIM, OFER |
分类号 |
A61K47/48;C12N15/52;C12N15/62;(IPC1-7):G01N33/53;C07K16/46;G01N33/567 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|